AhR activation has been shown to upregulate ALDH in oral cancer [116] and breast cancer [117], while in triple-negative breast cancer, AhR inhibition reduced chemoresistance in ALDHhigh tumors [37]. The gene discussed is AHR; the disease is triple-negative breast carcinoma.